CureVac
CureVac is a biopharmaceutical company focused on developing mRNA-based therapeutics and vaccines. Their mission is to harness the potential of mRNA technology to create innovative solutions for disease prevention and treatment, aiming to improve global health.
Industries
biotechnology
medical
pharmaceutical
Nr. of Employees
large (251-1000)
Products
Prophylactic vaccine candidates
Preventive vaccine candidates developed using RNA-based platforms, undergoing preclinical and clinical evaluation.
Oncology vaccine candidates
Therapeutic vaccine candidates targeting cancer-related antigens intended to stimulate anti-tumor immune responses.
Prophylactic vaccine candidates
Preventive vaccine candidates developed using RNA-based platforms, undergoing preclinical and clinical evaluation.
Oncology vaccine candidates
Therapeutic vaccine candidates targeting cancer-related antigens intended to stimulate anti-tumor immune responses.
Services
Scientific review and article publication
Preparation and dissemination of review articles summarizing scientific and clinical evidence in relevant therapeutic areas.
Scientific review and article publication
Preparation and dissemination of review articles summarizing scientific and clinical evidence in relevant therapeutic areas.
Expertise Areas
- mRNA-based therapeutics and vaccines
- Oncology vaccine development
- Prophylactic vaccine development
- Mechanistic immunology
Key Technologies
- mRNA therapeutic platforms
- RNA delivery and formulation
- Immunogenicity assays
- Preclinical in vivo models